跳至主要内容
临床试验/EUCTR2006-004073-10-DE
EUCTR2006-004073-10-DE进行中(未招募)不适用

Effect of Atomoxetine and a standardized behavior therapy on attention deficits in adult ADHD - Atomoxetine and adult ADHD

niversity of Giessen0 个研究点开始时间: 2006年8月16日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Actual diagnosis of ADHD according to DSM IV
  • Age 18 to 50
  • Both sexes
  • Declaration of informed consent for all clinical measures
  • Normal IQ (Estimated by a short IQ test during the screening)
  • Normal ECG findings
  • Sufficient knowledge of the German language to follow instructions and training procedure
  • In- and out-patients
  • Consent to a highly effective birth control method (failure rate less than 1%) for female patients in childbearing years
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Other psychiatric disorder according to DSM IV
  • Any neurological disorder
  • Tachykardia, hyperpiesia or very low blood pressure
  • Liver malfunctions
  • Contraindication for the usage of Atomoxetine as listed in the companies safety information
  • Intake of antibiotics, azol-antimycotics, antihistamines or antiarrhythmics
  • History of allergic reaction to Atomoxetine
  • Female patients who are pregnant or nursing
  • Other medication that affects the central nervous system
  • Paticipation in other clinical trials

研究者

发起方
niversity of Giessen

相似试验

Effect of Atomoxetine and a standardized behavior... | 临床试验